Our response and support

How you can help

Resources and trusted information

Society news and updates

COVID-19 safety at our events

Junior School (ages 7-11)

Senior school (ages 11-16)

Students (ages 16+)

Undergraduate

Postgraduate and early career

Clinical Pharmacology: for medical students

Beyond Medical School

School teacher or careers advisor

Pharmacology Educator

Where can pharmacology take me?

Case Studies

Finding Funding

Jobs & opportunities

Latest News

Blog

Events calendar

Propose an event

Sponsor our meetings & events

Abstracts guidance & advice

Bursaries

Code of conduct for meetings and events

COVID-19 safety at our events

List an event

About BPS education

Teaching pharmacology

Society training opportunities

Engagement

Ambassadors Scheme

Educational Resources

Clinical pharmacology

Prescribing and patient safety

Animal research

Why partner with the British Pharmacological Society?

Our reach

Partnership case studies

Our principles for working with commercial third-party partners

Get in touch

Blog

Pharmacology Matters

British Journal of Pharmacology

British Journal of Clinical Pharmacology

Pharmacology Research & Perspectives

Guide to PHARMACOLOGY

Become a peer reviewer

Society membership

Prizes, awards and grants

Awards Terms & Conditions

Bursaries

My BPS

Get involved

Documents and forms

Omeprazole does not affect measured CYP3A4 activity using the erythromycin breath test [letter]

Article date: October 1995

By: T Tateishi, SG Graham, Y Krivoruk, AJ Wood, in Volume 40, Issue 4, pages 411-412

DOI: 10.1111/j.1365-2125.1995.tb04566.x

View this article

Share this page

Previous

Modelling the market uptake of new drugs following listing for subsidy in Australia. A report from the Drug Utilisation Subcommittee of the Australian Pharmaceutical Benefits Advisory Committee.

Publishing